Which cisplatin schedule is safer for head and neck cancer patients?
Disease control
Ongoing
This study compares two ways of giving the chemotherapy drug cisplatin alongside standard radiation for people with locally advanced head and neck cancer. One group gets cisplatin every three weeks, the other gets it weekly. The goal is to see which schedule causes fewer severe s…
Phase: PHASE2 • Sponsor: Susanne Arnold • Aim: Disease control
Last updated May 12, 2026 13:43 UTC